Pedicure Manicure kit Beauty Equipment.
Injection molded from medical grade FHR polypropylene our swab is based on the Harvard Wyss Institute Design and meets the specifications of Health Canada. The swab is also registered with the FDA. Our process allows us to produce approximately 60,000 swabs daily and are ideal for testing or to be included in test kits. The price includes gamma sterilization and individually packaged. Website is www.covidtestswab.com Specifications are as follows: Overall swab length 149.80 mm Breakpoint distance from tip 75.75 mm Swab tip length 20 mm
Due to contractual obligations to the federal government, Current suppliers have increased costs and limited production of all point of care tests without notice. We have great news! To shield our customers from excessive price increases as well as provide immediate availability, we have secured multiple FDA EUA rapid antigen test kit options. These tests have similar and/or better accuracy along with individual buffer bottles. We are currently able to provide three options: Clarity-Sienna, Indicaid and Celltrion DiaTrust kits. We work directly with the distributor and can supply by the pallet or case with pricing as low as $6.00 per kit.
CLIA Waived Use of this test with all authorized specimen types is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet requirements to perform moderate or high complexity tests. This test is also authorized for use with fingerstick whole blood specimens only at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. The CLIA Waived COVID-19 IgG/IgM Rapid Test Device is an in vitro immunoassay for the direct and qualitative detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum, or plasma. The test is for professional use only. Indication: Qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human venous whole blood (sodium EDTA), serum, or plasma (sodium EDTA). Intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. Emergency use of this test is limited to authorized laboratories. About Test Device EUA Authorized CE Mark Test does NOT give positive or negative result for COVID-19 virus. This is an antibody test, it only indicates past or recent infection. Read Results in 15 Minutes 9 Month Expiration from Date of Manufacture Contents 20 Test Devices 20 Disposable Pipettes 20 Alcohol Prep Pads Sterile Safety Lancets Buffer Package Insert
The CareStart COVID-19 Antigen Test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal or anterior nasal swab specimens directly collected from individuals who are either suspected of COVID-19 by their healthcare provider within the first five days of symptom onset or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet the requirements to perform moderate, high, or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., inpatient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. Lateral flow assay Detect SARS-CoV-2 nucleocapsid protein antigen Rapid results within 10-15 minutes Intended at POC setting (i.e., in patient care settings) by medical professionals operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation For use under the Emergency Use Authorization (EUA) only For in vitro diagnostic use only For prescription use only For use with direct anterior nasal and nasopharyngeal swab specimens Clinical Performance 93.75% PPAa and 99.32% NPAb when used with nasopharyngeal swab 87.18% PPAa and 100% NPAb when used with anterior nasal swab
Master Carton - Contains 625 Tests For International Sale Only - Call for Pricing The COVID-19 IgG/IgM Rapid Test Device is an in vitro Immunoassay for the direct and qualitative detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum, or plasma. The test is for professional use only. Indication: Qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human venous whole blood (sodium EDTA), serum, or plasma (sodium EDTA). Intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. About Test Device Gives Positive or Negative Result for COVID-19 IgM/IgG antibodies Read Results in 15 Minutes Contents of each box 25 Test Devices 25 Disposable Pipettes 25 Alcohol Prep Pads Sterile Safety Lancets Buffer Package Insert
STANDARD M nCoV Real-Time Detection kit is used for rapid identification and detection of novel coronavirus (2019-nCoV) nucleic acids in human nasopharyngeal swabs and throat swab samples. - One tube reaction for identification and detection of 2019-nCoV - One-step Real-Time RT-PCR - Provide all reagents required for PCR - Designed according to WHO interim guidance for laboratory testing for 2019 novel coronavirus (2019-nCoV) in humans" - nCoV primers/probes ORF1ab (RdRp) gene, E gene Provide Internal controls Kindly check ghope-ppe.com. All information is for a consumer. If you want to buy a bulk, please contact us.
PPE COVID home test kit supply to worldwide. Shipping: CIF Payment: L/C MOQ: 100,000pcs
Access Bio Covid 19 Antigen Test Kit Care Start The CareStart COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in swab specimens directly collected from symptomatic individuals who are suspected of COVID-19 by their healthcare providers.
Product Description FDA EUA, CE Price of product ( USD price or FOB price) : "10,000-99,999: $8.45 100,000-249,999:$7.98 250,000-499,999: $7.78 500,000+: Contact" Product origin : China Minimum Order Size and Packgaing details : 10,000 Individual tests (25/box)
The test shows the presence in blood or serum of HIV antibodies (both type 1 and type 2).
Highest accuracy Fast result interpretation Cost effective Made with best choices of materials Type: immunoassay system Brand name: ntbio/oem/private label Place of origin: british columbia, canada Size: 60mm x 300mm Accuracy: 99.9% Sensitivity: 20 miu/ml Specimen: urine .
We have just achieved a major breakthrough in the development of dengue igg/igm antibody early test. Our new product is capable to detect the presence of dengue igm antibody in human serum within 3-5 days since primary infection (tested and verified with reference standard blood sample from usa cdc), while similar products currently found on the market can only detect it after at least 10-15 days. The significance of this achievement is that the new dengue igg/igm antibody early test now can diagnose dengue infection at a very early stage, which previously could only be done with a dengue ns1 antigen test. Type: immunoassay system Brand name: ntbio/oem/private label Place of origin: british columbia, canada Size: 60mm x 300mm Sensitivity: 95.3% Specificity: 95.0% Specimen: whole blood/serum/plasma .
Highest accuracy Fast result interpretation Cost effective Made with best choices of materials Type: immunoassay system Brand name: ntbio/oem/private label Place of origin: british columbia, canada Size: 60mm x 300mm Sensitivity: 94.3% Specificity: >98.9% Specimen: whole blood/serum/plasma .
Highest accuracy Fast result interpretation Cost effective Made with best choices of materials Type: immunoassay system Brand name: ntbio/oem/private label Place of origin: british columbia, canada Size: 60mm x 300mm Accuracy: 99.9% Sensitivity: 20 miu/ml Specimen: urine .
Highest accuracy Fast result interpretation Cost effective Made with best choices of materials Type: immunoassay system Brand name: ntbio/oem/private label Place of origin: british columbia, canada Size: 60mm x 300mm Cut-off value: 1000 ng/ml Sensitivity: 99.5% Specificity: >99.7% Specimen: urine .
Rapid Test Kit COVID-19 IgG/Igm. Standard certification. FDA CE 38220090.00 ( Including in the WHO listing) MQO 10,000 units
COVID-19 Rapid 99% Accuracy Mouth Testing Kits: Serology Antibody Testing $49.97 (FDA APPROVED) It is a 10-minute test that does not require a machine. â?¢ Antigen Rapid Testing $59.97 (FDA Emergency Use Authorization - EUA) It is a 20-minute test that does not require a machine or cold chain logistics� (as compared to PCR swab tests). Volume Discounts 10,000 plus units $5 per kit discount 20,000 plus units $7 per kit discount 50,000 plus units $10 per kit discount *Special Discount Structure for (immediate) higher volume orders* Please email for more information.
Our COVID-19 rapid test kit can be used effectively on many levels for proper screening and strategic preparedness toward the pandemic. The test kit requires no sophisticated equipment nor laboratory settings. Our SARS-COV-2 Antibody Rapid Test Kit can be applied for screening of COVID-19 disease on the following: General practitioners and external clinics level to detect previous SARS-COV-2 viral infections on both symptomatic and asymptomatic patients. Determination of the immunity level of front-line healthcare workers, which can help in the development of pandemic preparedness strategies at national levels. Epidemiological COVID-19 surveys at national and district levels for research purposes. Airport screening for arriving /departing passengers to control the pandemic in the aviation industry. Suspected cases exclusion to minimize cost and time spent in the RT-PCR testing procedures. Screening on the national level to facilitate decision making regarding lockdown and curfew easing strategies. Phoenix Bioscience is offering a competitive price for a high-quality kit that is made in Canada and used currently to combat the pandemic in most American cities.
We at Phoenix Bioscience would like to offer you our COVID-19 rapid detection kit based on detecting SARS-COV-2 IgG and IgM and delivers results within 15 minutes. Made in Canada, CE certified. Packaging Details: Each package contains 25 individually packed tests, the buffer used in the detection procedure, and disposable pipettes for blood samples collection Phoenix Bioscience is offering a competitive price for a high-quality kit
